01901oam 2200433I 450 991070797530332120170124121941.0(CKB)5470000002468813(OCoLC)969906160(EXLCZ)99547000000246881320170124j201612 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierConsolidated guidance about materials licenses program-specific guidance about commercial radiopharmacy licenses, draft report for comment /prepared by R. L Elliot [and five others]Rev. 2.Washington, DC. :United States Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards,December 2016.1 online resource (various pagings) illustrations"NUREG-1556, volume 13, Rev. 2.""Manuscript completed: December 2016; date published: December 2016.""Performing organization: Division of Material Safety, State, Tribal, and Rulemaking Programs, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission"--Bibliographic data sheet.Consolidated guidance about materials licenses RadiopharmaceuticalsUnited StatesRadioisotopes in pharmacologyUnited StatesNuclear industryLicensesUnited StatesRadiopharmaceuticalsRadioisotopes in pharmacologyNuclear industryLicensesElliot R. L.1389626U.S. Nuclear Regulatory Commission.Office of Nuclear Material Safety and Safeguards,GPOGPOGPOBOOK9910707975303321Consolidated guidance about materials licenses3441449UNINA